Missouri to issue 48 marijuana microbusiness licenses in October

April 29, 2023 · MJ Biz Daily

Missouri plans to license an initial round of 48 cannabis microbusinesses, to be awarded via a lottery in October.

The microbusiness licenses “are designed to allow marginalized or under-represented individuals to participate in the legal marijuana market,” according to new release issued by the Missouri Department of Health and Senior Services (DHSS).

Microbusiness retail licenses will be available to medical marijuana and adult-use retailers; wholesale licenses will permit cannabis cultivation and manufacturing.

Microbusiness wholesale facilities may grow up to 250 flowering cannabis plants at once, according to a cannabis microbusiness FAQ offered by the DHSS.

The regulator lists a variety of eligibility requirements for the microbusiness license type, including prioritizing people with previous marijuana offenses.

The first application window for microbusiness licenses will be open from July 27 through Aug. 10, with application forms available by June 6, according to the DHSS.

“In October, DHSS will issue, via random lottery drawing, six microbusiness licenses in each of the eight Missouri congressional districts, for a total of 48 microbusiness licenses,” the agency noted.

“Of the six in each district, two will be microbusiness dispensaries, and four will be wholesale facilities.”

The DHSS plans to issue 48 more microbusiness licenses per year in 2024 and 2025.

Adult-use marijuana sales in Missouri launched in February, and combined recreational and medical cannabis sales totaled $126.2 million in March,

As with many other new adult-use cannabis markets, Missouri consumers experienced product shortages and high prices after the market expanded beyond medical sales. (Full Story)

In category:Business
Next Post

‘Unprecedented’: The biggest Calif. pot farm keeps getting bigger

Glass House Brands, a Long Beach company widely considered to run the largest cannabis farm in California, is growing pot inside 2 million square feet of Southern California greenhouses. At any given time, the company has 750,000 pot plants in…
Read
Previous Post

Schwazze expands New Mexico cannabis footprint through $38 million acquisition

Colorado-based cannabis multistate operator Schwazze is deepening its presence in New Mexico with the planned acquisition of certain assets belonging to Sucellus. The acquisition of not-for-profit Everest Apothecary is valued at approximately $38 million, according to a news release. The transaction involves…
Read
Random Post

Is Big Tobacco Really Trying to Get into the Cannabis Industry By Using Trademark Lawsuits on Rolling Papers and Cones?

As the legal marijuana industry grows and gains wider acceptance, a new conflict looms on the horizon. Big Tobacco, well-known for its influence in the tobacco industry, is now focusing on the flourishing cannabis market. The gradual legalization of marijuana…
Read
Random Post

Cannabis and Criminal Justice Advocates Urge Biden to Fully Deschedule Cannabis

In a letter to President Joe Biden (D), the Marijuana Justice Coalition and Cannabis Freedom Alliance said that the administration’s plans to move cannabis from Schedule I to Schedule III under the Controlled Substances Act “would simply maintain federal criminalization” of state-approved medical…
Read
Random Post

New PA law could increase medical marijuana dispensary permits by 20%

Up to 30 new medical marijuana dispensaries could open in Pennsylvania under a bill signed into law by the state’s Democratic governor, a potential expansion of 20%. Under Senate Bill 773 – which Gov. Josh Shapiro signed into law Dec. 14, as…
Read
Random Post

DEA Official Says New Rules Are Coming For Synthetic Cannabinoids, Including CBD And Delta-8 THC

The Drug Enforcement Administration (DEA) will soon be proposing new rules to clarify that synthetically manufactured cannabinoids like delta-8 THC are prohibited controlled substances. At the agency’s 2023 Supply Chain Conference earlier this month, Terrance Boos, chief of DEA’s Drug…
Read